BackPerspective Therapeutics Overview

Perspective Therapeutics Cost of Revenue

Cost of Revenue analysis for CATX.

Quarterly Cost of Revenue

$1.13M
↑ 53.83% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$2.61M
↑ 256.56% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin